| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.1 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.045 | 0.1 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.2 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.09 | 0.2 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.2 |
| mRNA | PD-0332991 | FIMM | pan-cancer | AAC | -0.23 | 0.2 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |